Myelodysplastic syndromes (MDS): prognostic factors and scoring systems

Myelodysplastic syndromes (MDS): prognostic factors and scoring systems

OBJECTIVE: To evaluate the score systems of Cassano and Sanz and suggest a new one. DESIGN: Case series. LOCATION: Teaching hospitals: EPM UNIFESP and Faculdade de Medicina de Botucatu. PARTICIPANTS: 59 patients diagnosed from 1979 to 1992. INTERVENTION: Evaluation of clinical-laboratorial data. MEA...

Full description

Bibliographic Details
Main Authors:	Elizabeth Xisto Souto, Maria de Lourdes Lopes Ferrari Chauffaile, José Eduardo Cajado Moncau, Lígia Niero-Melo, Gisele Wally Braga, Maria Regina Regis Silva, José Kerbauy
Format:	Article
Language:	English
Published:	Associação Paulista de Medicina
Series:	São Paulo Medical Journal
Subjects:	Myelodysplastic syndromes Prognosis Survival
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-31801997000500005&lng=en&tlng=en

Similar Items

Myelodysplastic syndromes: histopathology as prognostic factor
by: Romeo Maura, et al.
Published: (2001-01-01)

Assessing the Prognosis of Patients with Myelodysplastic Syndromes (MDS)
by: Gattermann, N., et al.
Published: (2022)

Myelodysplastic syndrome: classification and prognostic systems
by: Rosangela Invernizzi, et al.
Published: (2011-12-01)

Autophagy Gene Panel-Based Prognostic Model in Myelodysplastic Syndrome
by: Ming-Jing Wang, et al.
Published: (2021-02-01)

Management of myelodysplastic syndromes: Expert consensus opinion from the Saudi MDS Working Group
by: Ahmed Alaskar, et al.
Published: (2014-01-01)

Risk-Adapted, Individualized Treatment Strategies of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)
by: Jan Philipp Bewersdorf, et al.
Published: (2021-03-01)

NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
by: Francesco D'Alò, et al.
Published: (2010-08-01)

NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
by: Mariangela Greco, et al.
Published: (2010-05-01)

Current State and Challenges in Development of Targeted Therapies in Myelodysplastic Syndromes (MDS)
by: Michele Stanchina, et al.
Published: (2021-04-01)

Emerging Therapies for the Myelodysplastic Syndromes
by: Jonathan Canaani
Published: (2019-12-01)

Complex karyotype in myelodysplastic syndromes: Diagnostic procedure and prognostic susceptibility
by: Mohammad Shahjahani, et al.
Published: (2019-02-01)

Chronic myeloid leukemia (CML): prognostic factors and survival analysis
by: Gisele Wally Braga, et al.

Prognostic Markers of Myelodysplastic Syndromes
by: Yuliya Andreevna Veryaskina, et al.
Published: (2020-07-01)

Prognostic markers of efficiency of immunosupressive therapy in patients with myelodysplastic syndrome
by: Ольга Ігорівна Бойко, et al.
Published: (2015-09-01)

Pathohistological characteristics of myelodysplastic syndromes: Diagnostic and prognostic significance
by: Marisavljević Dragomir, et al.
Published: (2005-01-01)

Effects of different doses of erythropoietin in patients with myelodysplastic syndromes: A propensity score‐matched analysis
by: Enrico Balleari, et al.
Published: (2019-12-01)

Myelodysplastic Syndrome (MDS) in a Child who Transformed to Acute Myeloid Leukaemia with Myelodysplasia-Related Changes (AML-MRC)
by: Ni Komang Ayu Parmawati, et al.
Published: (2019-08-01)

Fatores prognósticos nas síndromes mielodisplásicas Prognostic factors for myelodysplastic syndromes
by: Alexandre G. Apa, et al.
Published: (2006-09-01)

IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME
by: Rosangela Invernizzi, et al.
Published: (2015-04-01)

Study of myelodysplastic features in patients with myelodysplastic syndromes by multicolor flow cytometry
by: O. Yu. Davydova, et al.
Published: (2019-01-01)

The Differencies in Adult and Pediatric Myelodysplastic Syndrome: A Review
by: Vasekova P, et al.
Published: (2016-08-01)

The Evolving Landscape of Myelodysplastic Syndrome Prognostication
by: Jacob Shreve, et al.
Published: (2020-04-01)

Validation of International Working Group response criteria in higher‐risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research Consortium
by: Rami S. Komrokji, et al.
Published: (2021-01-01)

ROLE AND TIMING OF HEMATOPOIETIC CELL TRANSPLANTATION FOR MYELODYSPLASTIC SYNDROME
by: Teresa L Field, et al.
Published: (2010-07-01)

Immune dysregulation in myelodysplastic syndrome
by: Chiharu Sugimori, et al.
Published: (2010-01-01)

Localized lymphadenopathy with myelodysplastic syndrome associated with tuberculosis
by: Aya Nakaya, et al.
Published: (2019-11-01)

Current Therapy of the Patients with MDS: Walking towards Personalized Therapy
by: Maria Luisa Palacios-Berraquero, et al.
Published: (2021-05-01)

Síndrome mielodisplásica secundária à quimio ou radioterapia: SMD relacionada a tratamento Myelodysplastic syndrome secondary to chemo: and radiotherapy MDS related to the treatment
by: Ronald F. Pinheiro, et al.
Published: (2006-09-01)

Treatment of High-risk Myelodysplastic Syndrome
by: LI Shijun, et al.
Published: (2020-12-01)

RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
by: Julie Schanz, et al.
Published: (2015-04-01)

THROMBOCYTOPENIA IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES - STILL AN UNSOLVED PROBLEM
by: May Basood, et al.
Published: (2018-07-01)

Prognostic factors in de novo myelodysplastic syndrome in young and middle-aged people
by: Наталья Николаевна Климкович, et al.
Published: (2015-01-01)

Tissue doppler echocardiography detects preclinical markers of cardiac lesion in MDS patients
by: de Castro Cláudio César, et al.
Published: (2012-06-01)

Prognostic Value of Next-Generation Sequencing Data in Patients with Myelodysplastic Syndrome
by: NYu Tsvetkov, et al.
Published: (2019-03-01)

Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis
by: Ziqi Wan, et al.
Published: (2020-10-01)

Early detection of transformation to BPDCN in a patient with MDS
by: Kamal Chamoun, et al.
Published: (2018-10-01)

Abnormal Ferroptosis in Myelodysplastic Syndrome
by: Qi Lv, et al.
Published: (2020-09-01)

GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways
by: Laura Guerenne, et al.
Published: (2016-01-01)

Genetics of Myelodysplastic Syndromes
by: Caner Saygin, et al.
Published: (2021-07-01)

Myelodysplastic syndromes: Classification
by: Hans Peter Horny
Published: (2014-01-01)